Author:
Bromberg MB,Wald JJ,Forshew DA,Feldman EL,Albers JW
Subject
Clinical Neurology,Neurology
Reference14 articles.
1. Brunner, N.G., Berger, C.L., Namba, T. and Grob, D. (1996) Corticotropin and corticosteroids in generalized myasthenia gravis: comparative studies and role in management. Ann. NY. Acad. Sci., 274: 577–595.
2. Chaudhry, V., Cornblath, D.R. Immunosuppressive therapy for myasthenia gravis. In: Lisak, R.P., (Ed.) Handbook of myasthenia gravis and myasthenic syndromes. Marcel Dekker, New York, 1994, pp. 341–374.
3. Gajdos, P., Ekharrat, D., Chevret, S., Dhastang, C., Raphael, J.-C., Bolgert, F., Eymard, B., Woimant, F., Morcamp, D., Tournihac, M. and Dupuis, M. (1993) A randomized clinical trial comparing prednisone and azathioprine in myasthenia gravis. Results of the second interim analysis. J. Neurol. Neurosurg. Psychiatry, 56: 1157–1163.
4. Hohlfeld, R., Michels, M., Heininger, K., Besinger, U. and Toyka, K.V. (1988) Azathioprine toxicity during long-term immunosuppression of generalized myasthenai gravis. Neurology, 38: 258–261.
5. Kissel, J.T., Levy, R.J., Mendell, J.R., and Griggs, R.C. (1986) Azathioprine toxicity in neuromuscular disease. Neurology, 36: 35–39.
Cited by
57 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献